Grafa News and Videos — Page 233

Arvinas (NASDAQ:ARVN) dosed the first participant in a Phase 1/2 trial of ARV-6723, an investigational oral immuno-oncology candidate designed to degrade HPK1 in adults with advanced solid tumors.

Cosmos Health (NASDAQ:COSM) reported more than $20 million in implied revenue from Cana Laboratories’ contract manufacturing pipeline, based on management estimates over the expected duration of agreements.

Foresight Autonomous Holdings (NASDAQ:FRSX) signed a non-binding term sheet to acquire a 50.01% stake in a company advancing two data center projects in Poland.

TOYO (NASDAQ:TOYO) said it expects positive EBITDA for the second half of 2026 while withholding specific financial guidance due to ongoing U.S. trade and regulatory uncertainty.

Ethereum (ETH) has begun moving towards a 2030 architecture built around cryptographic proofs and decentralised computing.

AbbVie (NYSE:ABBV) received U.S. Food and Drug Administration approval for JUVMO (tavapadon) tablets to treat adults with Parkinson’s disease.

Maris-Tech (NASDAQ:MTEK) received a US$10 million order to develop and supply video systems for next-generation manned airborne platforms under a multi-year project with Magam Safety.

TransDigm Group (NYSE:TDG) completed its acquisition of Prince & Izant for approximately $1.066 billion in cash, including certain tax benefits.

Biohaven (NYSE:BHVN) will present updated Phase 1 data for BHV-1530 at the EORTC-NCI-AACR oncology symposium in November 2026, covering the ongoing BHV1530-101 study.

Bitget has resumed Bitcoin (BTC) withdrawals after a security breach affecting nearly $388 million.